Olatoyosi Odenike to Treatment Failure
This is a "connection" page, showing publications Olatoyosi Odenike has written about Treatment Failure.
Connection Strength
0.018
-
Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107. Leuk Lymphoma. 2008 Jul; 49(7):1274-8.
Score: 0.018